We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
-5.97%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$808M
AUM Growth
-$20.8M
Cap. Flow
+$35.8M
Cap. Flow %
4.43%
Top 10 Hldgs %
31.44%
Holding
237
New
60
Increased
70
Reduced
61
Closed
44

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$9.46M
2
DIS icon
Walt Disney
DIS
+$7.58M
3
ADBE icon
Adobe
ADBE
+$5.32M
4
CRM icon
Salesforce
CRM
+$5.02M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.1M

Sector Composition

Rank Sector Weight
1 Technology 16.68%
2 Healthcare 12.5%
3 Financials 10.48%
4 Consumer Staples 9.36%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PINS icon
176
Pinterest
PINS
$13.4B
$226K 0.03%
+9,166
New +$250K
HCAT icon
177
Health Catalyst
HCAT
$154M
$225K 0.03%
+8,627
New +$245K
SAM icon
178
Boston Beer
SAM
$1.91B
$224K 0.03%
+576
New +$240K
CYRX icon
179
CryoPort
CYRX
$761M
$223K 0.03%
6,375
-751
-11% -$28.4K
PHR icon
180
Phreesia
PHR
$663M
$223K 0.03%
+8,469
New +$260K
GH icon
181
Guardant Health
GH
$21.7B
$222K 0.03%
3,350
+392
+13% +$26.8K
OKTA icon
182
Okta
OKTA
$24.7B
$218K 0.03%
1,447
-246
-15% -$44.1K
BLFS icon
183
BioLife Solutions
BLFS
$1.53B
$213K 0.03%
9,374
-1,851
-16% -$48.7K
TWOU
184
DELISTED
2U Inc
TWOU
$212K 0.03%
531
+167
+46% +$67.2K
TWST icon
185
Twist Bioscience
TWST
$5.7B
$211K 0.03%
4,279
+1,337
+45% +$74.1K
VAW icon
186
Vanguard Materials ETF
VAW
$2.95B
$211K 0.03%
1,087
-378
-26% -$70.7K
HZO icon
187
MarineMax
HZO
$759M
$207K 0.03%
+5,130
New +$241K
ROKU icon
188
Roku
ROKU
$21.5B
$204K 0.03%
1,629
+494
+44% +$72.5K
ZM icon
189
Zoom
ZM
$28.2B
$200K 0.02%
1,709
+495
+41% +$67.3K
ADPT icon
190
Adaptive Biotechnologies
ADPT
$3.59B
$178K 0.02%
+12,797
New +$201K
EHTH icon
191
eHealth
EHTH
$42.2M
$168K 0.02%
+13,570
New +$234K
MVIS icon
192
Microvision
MVIS
$6.21M
$101K 0.01%
21,594
+11,133
+106% +$43.9K
HIVE
193
HIVE Digital Technologies
HIVE
$774M
$44K 0.01%
4,120
+1,601
+64% +$16.5K
ACAD icon
194
Acadia Pharmaceuticals
ACAD
$4.43B
-12,929
Closed -$302K
APPF icon
195
AppFolio
APPF
$6.38B
-2,992
Closed -$362K
APPS icon
196
Digital Turbine
APPS
$975M
-6,479
Closed -$395K
BAC icon
197
Bank of America
BAC
$435B
-254,772
Closed -$11.3M
BCRX icon
198
BioCryst Pharmaceuticals
BCRX
$2.28B
-45,953
Closed -$636K
BEAM icon
199
Beam Therapeutics
BEAM
$2.63B
-3,585
Closed -$286K
BLUE
200
DELISTED
bluebird bio
BLUE
-730
Closed -$146K

Similar funds

Spearhead Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Spearhead Capital Advisors held 237 positions worth $808M, down 2.5% from $828M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors deployed $35.8M of net new capital in Q1 2022, opening 60 new positions and adding to 70 existing holdings. Its largest new stake was Coinbase: 48,405 shares worth $9.19M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Consumer Discretionary ETF, an estimated $2.95M trimmed.

  • Spearhead Capital Advisors's largest Q1 2022 buy was Coinbase: 48,405 shares worth $9.19M.
  • Spearhead Capital Advisors added most to Walt Disney in Q1 2022, an estimated $7.58M increase.
  • Spearhead Capital Advisors's biggest Q1 2022 reduction was Vanguard Consumer Discretionary ETF, cutting an estimated $2.95M.
  • Spearhead Capital Advisors fully exited Bank of America in Q1 2022, selling an estimated $11.3M.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $808M portfolio in Q1 2022.
  • Spearhead Capital Advisors opened 60 new positions and closed 44 in Q1 2022.
  • Spearhead Capital Advisors's portfolio value fell 2.5% quarter-over-quarter to $808M.

Based on Spearhead Capital Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.